일리노이의 암 (전체) 임상 시험
암 (전체) 관련 연구 68개가 일리노이 내 여러 지역에서 참여자를 모집하고 있습니다.
일리노이의 도시
- Chicago연구 51개
- Cicero연구 12개
- Evanston연구 9개
- Peoria연구 7개
- Waukegan연구 6개
- Champaign연구 5개
- Naperville연구 5개
- Springfield연구 5개
- Aurora연구 4개
- Decatur연구 4개
- Arlington Heights연구 3개
- Charleston연구 3개
- Bloomington연구 3개
- Danville연구 3개
- Carbondale연구 3개
- Joliet연구 3개
공식 연구 텍스트(영어)
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- University of Illinois Chicago, Chicago
- Illinois Cancer Specialists, Niles
피험자 모집 중3상
18세 ~ 100세 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT05920356A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Hope And Healing Cancer Services /ID# 268536, Hinsdale
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT05650632RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Rush University Medical Center, Chicago
- University of Chicago Medical Center, Chicago
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT07002034Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- OSF Saint Anthony's Health Center, Alton
- Advocate Outpatient Center - Aurora, Aurora
- Advocate Good Shepherd Hospital, Barrington
- 외 56개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT06580314Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- Rush University Medical Center, Chicago
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT07195591Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- University of Illinois Cancer Center, Chicago
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT04198766A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- Northwestern Memorial Hospital, Chicago
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT06901531A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
- Hope and Healing Cancer Services, Hinsdale
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07169851A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
- City of Hope Chicago, Zion
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06150157A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- University of Illinois at Chicago, Chicago
- University of Chicago Hospital, Chicago
- Springfield Clinic Main Campus, Springfield
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06119581Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- Northwestern Memorial Hospital, Chicago
- University Of Chicago Medical Center, Chicago
피험자 모집 중2/3상
전 연령 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT03435796Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
- Lurie Children's Hospital, Chicago
피험자 모집 중2상
1세 ~ 26세 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT07680439Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
- Hope and Healing Clinical Research LLC, Hinsdale
- Hope and Healing Clinical Research LLC, New Lenox
- Illinois Cancer Specialists, Niles
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT07566156Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
- Chicago Cancer Center, Zion
피험자 모집 중1상
18세 이상 · 남성 · 2026. 10. 27. 업데이트됨 · NCT05997615Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
- Edward Hines Jr. VA Hospital, Hines, IL, Hines
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT02984761DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies
- Thoracic Surgery, Canning Thoracic Institute (Northwestern Memorial Hospital), Chicago
피험자 모집 중관찰 연구
18세 ~ 75세 · 모든 성별 · 2026. 10. 21. 업데이트됨 · NCT05671887A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
- University of Chicago Medical Center /ID# 278863, Chicago
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 20. 업데이트됨 · NCT07409246A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
- Research Site, Evanston
피험자 모집 중3상
18세 ~ 130세 · 모든 성별 · 2026. 10. 19. 업데이트됨 · NCT07647328A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Cancer Care Specialists of Illinois, Decatur
- Decatur Memorial Hospital, Decatur
- Hope and Healing Clinical Research LLC, Hinsdale
- 외 2개
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 10. 14. 업데이트됨 · NCT06989437A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)
- Northwestern University ( Site 0101), Chicago
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 13. 업데이트됨 · NCT07030712Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- Carle Cancer Center, Urbana
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT05386108A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
- University of Chicago Medical Center /ID# 274742, Chicago
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT07023289CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- Northwestern Memorial Hospital, Chicago
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 6. 업데이트됨 · NCT03328078uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
- Northwestern University, Chicago
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT05874921Registry Study for Radiation Therapy Outcomes
- OSF HealthCare Cancer Institute, Peoria
- Northwestern Medicine Chicago Proton Center, Warrenville
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT01255748A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
- Investigative Site, Chicago
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT06881992A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- University of Chicago Medical Center /ID# 280149, Chicago
- OSF St. Francis Medical Center /ID# 279930, Peoria
- Springfield Clinic - First /ID# 281309, Springfield
- 외 1개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07365241TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Cancer Treatment Centers of America-Chicago, Chicago
피험자 모집 중2상
12세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT02693535Evaluating the Communication Between Patients and Providers in Cancer Clinics
- Northwestern Memorial Hospital, Chicago
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT06985953The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials
- Rush-Copley Medical Center, Aurora
- Advocate Good Shepherd Hospital, Barrington
- Carle BroMenn Outpatient Center, Bloomington
- 외 17개
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT06756607Falcon Real World Evidence Registry
- Endeavor Health, Evanston
피험자 모집 중관찰 연구건강한 지원자 환영
50세 ~ 80세 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT06589310A Phase 1/1b Study of IAM1363 in HER2 Cancers
- University of Chicago, Chicago
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT06253871A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
- Northwestern University Feinberg School of Medicine, Chicago
- Cancer Care Specialists of Illinois, Decatur
- Illinois Cancer Care, Peoria
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06163534Ovarian Tissue Cryopreservation in Post Pubertal (OTC-Post Pubertal)
- Ann &Robert H Lurie Children's Hospital, Chicago
피험자 모집 중관찰 연구
30세 이하 · 여성 · 2026. 9. 3. 업데이트됨 · NCT05309746Ovarian Tissue Cryopreservation in Pre-Pubertal (OTC-Pre Pubertal)
- Ann & Robert H Lurie Childrens Hospital, Chicago
피험자 모집 중관찰 연구
11세 이하 · 여성 · 2026. 9. 3. 업데이트됨 · NCT05299710Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
- Insight Research Institute, Chicago
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06252649Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- Northwestern University, Chicago
- Southern Illinois University-Simmons, Springfield
- Carle Foundation Cancer Institute-Urbana, Urbana
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT06072612Project: Every Child for Younger Patients With Cancer
- Rush-Copley Medical Center, Aurora
- Lurie Children's Hospital-Chicago, Chicago
- Northwestern University, Chicago
- 외 16개
피험자 모집 중관찰 연구
25세 이하 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT02402244Abatacept in Immune Checkpoint Inhibitor Myocarditis
- University of Chicago, Chicago
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 20. 업데이트됨 · NCT05335928A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- University of Chicago Medical Center, Chicago
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT04104776ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.